CHIEF MED, SCI OFCR EVP ADVTEC
Minang (Mintu) Turakhia, M.D., M.A.S. is an internationally renowned cardiac electrophysiologist, outcomes researcher, and digital health executive serving as Chief Medical Officer, Chief Scientific Officer, and Executive Vice President of Advanced Technologies at iRhythm Technologies, Inc.[[1]](https://profiles.stanford.edu/minang-turakhia)[[2]](https://fintool.com/app/research/companies/IRTC/people/mintu-turakhia) He earned his B.S. in Molecular Biology and Computer Science from UC Berkeley, his M.D. from UC San Francisco, and an M.A.S. in Clinical Research, with clinical training at Harvard's Brigham & Women's Hospital and UCSF.[[2]](https://fintool.com/app/research/companies/IRTC/people/mintu-turakhia) Since joining iRhythm in June 2022, Dr. Turakhia has led significant operational expansion across Product Management, Advanced Technologies, Medical Affairs, Scientific Affairs, and Medical Safety, driving revenue growth of 20+% year-over-year for three consecutive years and launching award-winning hardware, software, and services while overseeing the company's product roadmap expansion into seven new European and Asian markets.[[1]](https://profiles.stanford.edu/minang-turakhia)
Throughout his career, Dr. Turakhia has held a tenured position as Clinical Professor of Medicine at Stanford University School of Medicine since 2008 and served as Chief of Cardiac Electrophysiology at VA Palo Alto Health Care System for 14 years, where he developed a high-volume arrhythmia care program.[[1]](https://profiles.stanford.edu/minang-turakhia)[[3]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Hiring-of-Dr.-Mintu-Turakhia-as-Chief-Medical-Officer-and-Chief-Scientific-Officer/default.aspx) He is an elected member of the American Society of Clinical Investigation and co-principal investigator of the landmark Apple Heart Study, which enrolled over 400,000 participants and was published in the New England Journal of Medicine.[[1]](https://profiles.stanford.edu/minang-turakhia)[[3]](https://investors.irhythmtech.com/news/news-details/2022/iRhythm-Technologies-Announces-Hiring-of-Dr.-Mintu-Turakhia-as-Chief-Medical-Officer-and-Chief-Scientific-Officer/default.aspx) With over 300 publications and more than $50 million in research funding, Dr. Turakhia has led the development and commercialization of FDA-cleared AI tools for ECG interpretation, connected cardiac monitoring products, and remote patient monitoring platforms, while serving as advisor, consultant, board member, or co-founder to over 30 medical device and health technology companies.[[1]](https://profiles.stanford.edu/minang-turakhia) In 2022, he received the Rock Health Digital Health Luminary Award for his contributions to digital health innovation.[[1]](https://profiles.stanford.edu/minang-turakhia)
View full insider profile →
